Ischemia, Cerebral Completed Phase 3 Trials for Ancrod (DB05099)

Also known as: Cerebral ischaemia / Cerebral Ischemia / TIA / Ischemia cerebrovascular / Ischaemia cerebral / Ischaemia cerebrovascular / Ischemia cerebral / Chronic cerebral ischemia

IndicationStatusPhase
DBCOND0083496 (Ischemia, Cerebral)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00343174Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms